Distance Learning at AIU is enhanced by vast academic resources and innovative technologies build into the Virtual Campus: Hundreds of self-paced courses with video lectures and step by step lessons, thousands of optional assignments, 140,000 e-books, the Social Media & Networking platform allowing collaboration/chat/communications between students, and MYAIU develop students holistically in 11 areas beyond just academics.
The world is YOUR campus!”, that is the message of AIU’s month magazine Campus Mundi. Hear the voices and see the faces that make up AIU. Campus Mundi brings the world of AIU to you every months with inspirational stories, news and achievements by AIU members from around the world (students and staff are located in over 200 countries).
What are the primary challenges associated with the oral delivery of RNA therapies, and how do milk-derived extracellular vesicles (EVs) address these challenges?
In what ways could the use of milk-derived EVs for RNA therapy delivery impact the treatment of diseases beyond the gastrointestinal tract?
What are the potential societal and economic implications of developing affordable and accessible oral RNA therapies using milk-derived EVs?
Based on your responses to the questions above, compose an essay that explores the innovative use of milk-derived extracellular vesicles (EVs) in overcoming the challenges of RNA therapy delivery. Discuss how this approach could transform the treatment of various diseases, not limited to gastrointestinal conditions, and analyze the broader societal and economic impacts of making oral RNA therapies more affordable and accessible. Your essay should demonstrate a comprehensive understanding of the subject matter and provide a critical assessment of the potential benefits and challenges associated with this emerging therapeutic strategy.
(Login to your student section to access the AIU Additional Resources Library.)
In a groundbreaking experiment, UK scientists have explored a novel approach to drug delivery using an everyday substance—cows’ milk. This innovation has the potential to transform how we administer RNA therapies, a rapidly growing field in medicine that could treat conditions ranging from cancer to neurodegenerative disorders. Traditionally, RNA therapies have faced a significant challenge: stability. These molecules degrade easily, making delivery to target cells difficult. However, milk may provide a natural, safe, and effective method of transport, potentially leading to oral RNA treatments that eliminate the need for injections.
RNA-based drugs have already demonstrated their power, particularly with the development of mRNA vaccines for COVID-19, which helped control the pandemic. Now, scientists are looking beyond vaccines, aiming to use RNA to create targeted therapies for a wide range of diseases. The success of RNA therapies depends largely on how well they can be delivered into the body. The latest findings suggest that milk could be the key to overcoming one of the biggest hurdles in this field.
Before diving into how milk could help deliver RNA therapies, it’s essential to understand how RNA functions in the body and why it is such a promising tool for medicine.
RNA, or ribonucleic acid, is a molecule responsible for translating genetic instructions from DNA into proteins. These proteins are essential for carrying out nearly all biological processes in the body. When something goes wrong at the genetic level, diseases can develop due to defective or missing proteins. RNA therapies allow scientists to intervene in this process, instructing cells to either produce beneficial proteins or stop making harmful ones.
One of the best-known examples of RNA therapy in action is the mRNA vaccines for COVID-19. These vaccines teach cells to create a harmless version of the coronavirus’ spike protein, triggering an immune response. This technology can be expanded far beyond vaccines to include treatments for genetic disorders, cancers, and chronic illnesses. However, the biggest challenge in making RNA therapies widely available is finding a way to safely and effectively deliver RNA molecules into the body.
Despite their medical potential, RNA molecules are fragile and degrade quickly outside cells. If left unprotected, they can be destroyed by enzymes in the body before they reach their intended target. This is why scientists must develop delivery systems that can protect RNA molecules long enough for them to reach cells and perform their function.
Currently, the most common way to deliver RNA therapies is through lipid nanoparticles (LNPs)—tiny fat-based particles that encase RNA molecules and shield them from destruction. While effective, LNPs can sometimes cause immune system reactions, leading to side effects like fever and inflammation. Additionally, RNA therapies are almost always administered via injections, as the harsh environment of the digestive system quickly breaks them down, making oral delivery impossible—until now.
In a major breakthrough, scientists at King’s College London have found that milk could be a game-changer in RNA therapy delivery. Milk is not just a nutritional beverage; it contains natural bioactive compounds, including proteins and lipids, that could help protect and transport RNA molecules safely through the digestive system.
Milk’s composition makes it a promising candidate for oral RNA drug delivery. Researchers have discovered that extracellular vesicles found in milk can encapsulate RNA molecules, protecting them from stomach acid and digestive enzymes. These vesicles act as tiny protective bubbles that help RNA reach the bloodstream and target cells without being destroyed.
The key to milk’s success as an RNA carrier lies in its structure and natural properties:
Early experiments have been conducted in rats to test the effectiveness of milk-based RNA delivery. The results have been promising: RNA molecules delivered through milk successfully reached target tissues without being degraded in the digestive system. These findings suggest that oral RNA therapies could soon become a reality, making it easier and more convenient for patients to take life-saving medications.
The use of milk as an RNA carrier opens up a world of possibilities for medical treatments. Some of the most exciting potential applications include:
RNA therapies could be used to target and silence cancerous genes, stopping tumor growth at the molecular level. Delivering RNA through milk could make these treatments more accessible, reducing the need for frequent hospital visits for injections.
Neurodegenerative diseases like Alzheimer’s and Parkinson’s could benefit from RNA therapies that help protect brain cells. Since milk has natural components that cross the blood-brain barrier, it could be an ideal carrier for delivering RNA therapies to treat or slow the progression of these disorders.
Many inherited diseases, such as cystic fibrosis and muscular dystrophy, result from genetic mutations that disrupt protein production. RNA therapies could correct these mutations at the molecular level, offering new hope for patients with previously untreatable conditions.
Conditions like rheumatoid arthritis, multiple sclerosis, and type 1 diabetes result from the immune system attacking healthy cells. RNA therapies could help regulate immune responses and prevent further damage to the body.
With advances in genetic research, RNA therapies could be tailored to individual patients based on their genetic makeup. This personalized approach could improve treatment outcomes and reduce side effects.
While using milk to deliver RNA therapies is a promising innovation, there are still challenges to address before it becomes a widely available treatment option. Some of these challenges include:
The idea of using milk to deliver RNA therapies represents a major step forward in medicine. If successful, it could lead to a revolution in drug delivery, making life-saving treatments easier to administer, more effective, and more widely available.
The discovery that milk can be used to deliver RNA therapies is a significant breakthrough that could transform modern medicine. This natural, safe, and efficient delivery system has the potential to make RNA treatments more accessible and convenient, opening new doors for treating countless diseases. As research progresses, the dream of taking RNA-based medications orally instead of injections may soon become a reality, improving patient care and revolutionizing the way we approach medicine.
If you are passionate about cutting-edge scientific discoveries and want to be part of the future of innovation, join Atlantic International University (AIU) today! At AIU, we encourage independent thinking, groundbreaking research, and real-world applications that drive change in science, healthcare, and technology. Take the next step toward your academic and professional goals—enroll at AIU and become a leader in shaping the future of medicine and beyond!
Nanotechnology in Drug Delivery Minicourse
The Future of Cancer Treatment
References
Reminder to our Dear Students,
Please ensure you are logged in as a student on the AIU platform and logged into the AIU Online
Library before accessing course links. This step is crucial for uninterrupted access to your learning
resources.
Begin Your Journey!
AIU’s Summer of Innovation and Growth gives you the ability to earn up to $5000 in tuition credit by completing free lessons and courses.
Whether you’re looking to acquire new skills, advance your career, or simply explore new interests, AIU is your gateway to a world of opportunities. With free access to 3400 lessons and hundreds of courses the ability to earn credits and earn certificates there’s no better time to start learning.
Join us today as a Guest Student and take the first step towards a brighter, more empowered future.
Explore. Learn. Achieve.
"*" indicates required fields
"*" indicates required fields
"*" indicates required fields